Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,591
Active & Responsive
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: New York NY, Philadelphia PA, Chapel Hill NC,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07489651
Phase 2, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
for
Alcohol Use Disorder
Location: Philadelphia PA, Durham NC, Orlando FL, Cleveland OH,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT07218354
Phase 3, Recruiting
Active & Responsive
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for
Post Traumatic Stress Disorder
Location: Worcester MA, New York NY, Toms River NJ, Princeton NJ,
Sponsor: Transcend Therapeutics
Sex: All
Age: 18+
Code: NCT07456696
Phase 3, Recruiting
Active & Responsive
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
for
Diabetic Peripheral Neuropathic Pain
Location: New Bedford MA, Waltham MA, Hamden CT, Rochester NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07285018
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: New York NY, King of Prussia PA, Washington D.C. DC,
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: Abbott Medical Devices
Sex: All
Age: 22 - 70
Code: NCT06423430
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Fredericton, Boston MA, Cromwell CT, Quebec,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase 2, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Portland ME, Boston MA, Providence RI, Stamford CT,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Active & Responsive
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
for
Acute HIV Infection
Location: Philadelphia PA, Columbus OH, Atlanta GA, Birmingham AL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70
Code: NCT05719441
Phase 2, Recruiting
Active & Responsive
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Boston MA, Burlington MA, Farmington CT, Lebanon NH,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase 2, Phase 3, Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
Increasing Germline Genetic Testing for Patients With Cancer
for
Hereditary Pancreatic Cancer, Conditions or Focus of Study,